Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treatment using exendin peptides or GLP-1 peptides

Methods of treatment using exendin peptides or GLP-1 peptides

US Patent 8759291 · Granted Jun 24, 2014

Estimated economic value: $36,644,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for treating metabolic disorders2024
Methods of treating a patient afflicted with non-alcoholic steatohepatitis (NASH2024
Glucagon-receptor selective polypeptides and methods of use thereof2023
Biguanide compositions and methods of treating metabolic disorders2023
Methods comprising continuous administration of exenatide and co-administration 2023
Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity,2022
Glucagon-receptor selective polypeptides and methods of use thereof2022
Detection of rare sequence variants, methods and compositions therefor2021
Biguanide compositions and methods of treating metabolic disorders2021
Methods comprising continuous administration of a GLP-1 receptor agonist and co-2020
Biguanide compositions and methods of treating metabolic disorders2020
Chemosensory receptor ligand-based therapies2020